Summary
An extended follow-up study of hepatitis C virus (HVC) infection was conducted in Guangzhou and its nearby regions on patients hospitalized with acute hepatitis. Routine screening of blood donors for HCV was not yet instituted at the time of this study. HCV was found to be a common cause of the disease, and the infection had a close association with recent histories of blood transfusion. Sequential sera obtained from patients during hospitalization and after discharge were tested for the presence of HCV antibodies by the first and the second generation of commercial test kits, for levels of alanine aminotransferase (ALT), and for the presence of HCV-RNA. The development of HCV antibodies in some of the patients may be delayed for protracted period following clinical onset. HCV-RNA was only intermittently detectable both before and after seroconversion. Six of 33 patients studied showed seroreversion and 5 of them were accompanied by loss of HCV-RNA and serum ALT returned to normal levels. The disease persisted in 24 of 27 patients without seroreversion, accompanied by intermittent detection of HCV-RNA throughout the protracted course of the infection. Our results indicate that both EIA for detection of HCV antibodies and PCR for serum HCV-RNA should be used in combination for reliable diagnosis of HCV infection and screening of blood for transfusion.
Similar content being viewed by others
References
Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ (1991) Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 325: 1325–1329
Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321: 1494–1500
Bradley D, Krawczynski K, Eberg J, McCaustland K, Choo QL, Houghton M, Kuo G (1990) Parenterally transmitted NANB hepatitis: virus-specific antibody response patterns in hepatitis C virus infected chimpanzees. Gastroenterology 99: 1054–1060
Bruix J, Barrera JM, Calvet X, Ercilia G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Castillo R, Rodes J (1989) Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 2: 1004–1006
Bukh J, Purcell RH, Miller RH (1992) Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 89: 187–191
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362
Choo QL, RIchman H, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M (1991) Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88: 2451–2455
Choo QL, Ralston R, Kuo G, Weiner A, Chien D, Van Nest G, Han J, Muchmore E, Houghton M (1993) Recombinant vaccine approaches to preventing HCV disease. The 8th Triennial International Symposium on Viral Hepatitis and Liver Disease, May 1993, Tokyo, Japan (Plenary Section No. P34).
Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M (1989) Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 2: 1006–1008
Enomoto N, Takada A, Nakao T, Date T (1990) There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 170: 1021–1025
Esteban J, Esteban R, Viladomiu L, Gonzalez A, Lopez-Talavera JC, Gonzalez A, Hernandez JM, Roget M, Vargas V, Genesca J, Buti M, Guardia J, Houghton M, Choo QL, Kuo G (1989) Hepatitis C virus antibodies among risk groups in Spain. Lancet 2: 294–297
Esteban JI, Gonzalez A, Hernandez JM, Viladomiu L, Sanchez C, Lopez-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J (1990) Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 325: 1107–1112
Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH (1991) A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325: 98–104
Farci P, London WT, Wong DC, Dawson GJ, Villari DS, Engle R Purcell RH (1992) The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viraemia. J Infect Dis 165: 1006–1011
Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, Tedder RS (1990) Demonstration of viraemia patterns in hemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet 336: 1022–1025
Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohbo K (1991) Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 175: 220–228
Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A, Walter E, Blum HE, Roggendorf M, Deinhardt F (1990) Long-term follow-up of post transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus. J Hepatol 10: 69–76
Japanese Red Cross Non-A, Non-B Hepatitis Research Group (1991) Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 338: 1040–1041
Kato N, Ohkoshi S, Shimotohno K (1989) Japanese isolates of the non-A, non-B hepatitis viral genome show sequence variations from the original isolated in the U.S.A. Proc Jpn Acad 65: 219–223
Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K (1990) Sequence diversity of hepatitis C viral genomes. Mol Biol Med 7: 495–501
Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671–675
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362–364
Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339: 237–238
Lanford RE, Notvall L, Barbosa LH, Eichberg JW (1991) Evaluation of a chimpanzee colony for antibodies to hepatitis C virus. J Med Virol 34: 148–153
Larsen J, Skaug K, Maeland A (1992) Second-generation anti-HCV tests predict infectivity. Vox Sang 63: 39–42
Lazizi Y, Elfassi E, Pillot J (1992) Detection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reaction. J Clin Microbiol 30: 931–934
Lelie PN, Cuypers HTM, Reesink HW, Van der Poel CL, Winkel I, Bakker E, Exel Oehlers PJ, Vallari D, Allain JP, Mimms L (1992) Patterns of serological markers in transfusion transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol 37: 203–209
Lok ASF, Cheung R, Chan R, Liu V (1992) Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology 15: 1007–1012
Miyamura T, Saito I, Katayzma T, Kikuchi S, Tateda A, Houghton M, Choo QL, Kuo G (1990) Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA. Proc Natl Acad Sci USA 87: 983–987
Mortimer PP, Cohen BJ, Litton PA, Vandervelde EM, Brind AM, Hambling MH (1989) Hepatitis C virus antibody. Lancet 2: 798
Mosley JW, Aach RD, Hollinger FB, Stevens CE, Barbosa LH, Nemo GJ, Holland PV, Bancroft WH, Zimmerman HJ, Kuo G (1990) Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 263: 77–78
Okamoto H, Okada, S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M (1990) Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 60: 215–222
Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, Miyakawa Y, Mayumi M (1990) The 5′-terminal sequence of the hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Jpn J Exp Med 60: 167–177
Okamoto H, Kurai K, Okada S, Kurai K, Adahane Y, Sugai Y, Tanaka T, Fukuda S, Tsuda F, Mishiro S (1992) Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 188: 331–341
Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G (1990) Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547–6549
Schlauder GG, Leverenz GJ, Amann CW, Lesniewski RR, Peterson DA (1991) Detection of the hepatitis C virus genome in acute and chronic experimental infection in chimpanzees. J Clin Microbiol 29: 2175–2179
Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H (1992) Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 89: 5477–5481
Shindo M, Bisceglie AMD, Biswas R, Mihalik K, Feinstone SM (1992) Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis 166: 424–427
Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC (1993) Sequence variability in the 5′ non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 74: 661–668
Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H (1991) Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65: 1105–1113
Takeuchi K, Kubo Y, Boonmar S, Watanabe Y, Katayama T, Choo QL, Kuo G, Houghton M, Saito I, Miyamura T (1990) The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 71: 3027–3033
Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Yoshizawa K, Hayata T, Shimizu S, Nakatsuji Y, Koike Y, Furuta S (1991) Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis. J Med Virol 33: 117–122
Tibbs CJ, Palmer SJ, Coker R, Clark SK, Parsons GM, Hojvat S, Peterson D, Banatvala JE (1991) Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays. J Med Virol 34: 143–147
Van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo QL, Kuo G, Houghton M (1989) Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 2: 297–298
Van der Poel C, Reesink H, Plaisier AAD, Schaasberg W, Leentvaar Kuyper A, Bakker E, Exel-Oehlers PJ, Lelie PN (1990) Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 335: 558–560
Villa E, Ferretti I, Palma MD, Melegari M, Scaglioni PP, Trande P, Vechi C, Fratti N, Manenti F (1991) HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH). J Hepatol 13: 256–259
Wang JT, Wang TH, Lin JT, Sheu JC, Lee CZ, Chen DS (1992) Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens. Vox Sang 62: 21–24
Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, Choo QL, Houghton M (1990) Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 335: 1–3
Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, Saracco G, Choo QL, Houghton M, Han JH (1991) Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180: 842–848
Yousuf M, Nakano Y, Tanaka E, Sodeyama T, Kiyosawa K (1992) Persistence of viraemia in patients with type-C chronic hepatitis during longterm follow-up. Scand J Gastroenterol 27: 812–816
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tan, D., Im, S.W.K., Peng, W.W. et al. Follow-up study of acute hepatitis C. Archives of Virology 138, 71–84 (1994). https://doi.org/10.1007/BF01310039
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01310039